A resolution recognizing and supporting individuals born with congenital disabilities or malformations due to thalidomide exposure.

Bill 118 S.Res. 714 is a resolution that aims to recognize and support individuals who were born with congenital disabilities or malformations as a result of exposure to the drug thalidomide. Thalidomide was a medication that was prescribed to pregnant women in the 1950s and 1960s to treat morning sickness, but it was later found to cause severe birth defects in babies.

The resolution acknowledges the challenges faced by individuals who were affected by thalidomide exposure, including physical disabilities, health issues, and the need for ongoing medical care and support. It also recognizes the resilience and strength of these individuals in overcoming obstacles and advocating for their rights.

The resolution calls for increased awareness and education about thalidomide exposure and its effects, as well as for continued support and resources for individuals affected by congenital disabilities or malformations. It also encourages research and efforts to prevent similar incidents from occurring in the future. Overall, Bill 118 S.Res. 714 seeks to bring attention to the plight of individuals born with disabilities due to thalidomide exposure and to ensure that they receive the support and recognition they deserve.